PDS Biotechnology Corp Adjustments to Additional Paid in Capital, Warrant Issued
PDS Biotechnology Corp (PDSB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-13
- PDS Biotechnology Corp adjustments to additional paid in capital, warrant issued for the quarter ending 2026-06-30 was $1.05M, a 1.69% decline year-over-year.
- PDS Biotechnology Corp adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was $1.93M.
- PDS Biotechnology Corp adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $1.07M.
- PDS Biotechnology Corp adjustments to additional paid in capital, warrant issued for fiscal 2019 was $372.93K.
- PDS Biotechnology Corp adjustments to additional paid in capital, warrant issued for fiscal 2018 was $0.00.
- PDS Biotechnology Corp adjustments to additional paid in capital, warrant issued for fiscal 2015 was $3.73M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.05M 10-Q · filed 2026-08-13 | $1.05M derived: sum of 2 quarters · filed 2026-08-13 | $2.98M derived: sum of 3 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $1.93M derived: sum of 2 quarters · filed 2026-05-14 | |||
| 2025-12-31 | $1.93M 10-K · filed 2026-03-30 | ||||
| 2025-06-30 | $1.07M 10-Q · filed 2026-08-13 | $3.22M derived: sum of 2 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $2.15M 10-Q · filed 2026-08-13 | ||||
| 2022-09-30 | $1.71M 10-K · filed 2024-03-28 | ||||
| 2019-12-31 | $372.93K 10-K · filed 2021-03-18 | ||||
| 2019-03-13 | $372.93K 10-K · filed 2020-03-27 | ||||
| 2018-12-31 | -$342.11K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$342.11K derived: sum of 2 quarters · filed 2020-03-27 | -$342.11K derived: sum of 3 quarters · filed 2020-03-27 | $0.00 10-K · filed 2020-03-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $342.11K 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $342.11K 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $342.11K 10-Q · filed 2019-05-14 | ||||
| 2015-12-31 | $3.73M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |